The impact of COVID-19 on TB care in Brazil
Int J Tuberc Lung Dis
.
2023 Dec 1;27(12):941-943.
doi: 10.5588/ijtld.23.0300.
Authors
E R D Neto
1
,
T S Matos
2
,
A C Furtado Ferreira
1
,
M Bezerra-Santos
3
,
A G da Silva Junior
4
,
R F do Carmo
5
,
C D F de Souza
1
Affiliations
1
Department of Medicine, Federal University of Vale do São Francisco (UNIVASF), Petrolina, PE.
2
University of Pernambuco, Petrolina, PE.
3
Federal University of Alagoas, Arapiraca, AL.
4
Prefeitura Municipal de Juazeiro, Juazeiro, BA.
5
Postgraduate Programme in Health and Biological Sciences, and, Postgraduate Programme in Biosciences, UNIVASF, Petrolina, PE, Brazil.
PMID:
38042966
DOI:
10.5588/ijtld.23.0300
No abstract available
MeSH terms
Antitubercular Agents / therapeutic use
Brazil / epidemiology
COVID-19*
Humans
Tuberculosis* / drug therapy
Tuberculosis* / therapy
Substances
Antitubercular Agents